CAPR
NASDAQ · Biotechnology
Capricor Therapeutics Inc
$29.83
+0.23 (+0.78%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
+109.3% upside
Low Target
$34.96
Average Target
$62.44
High Target
$82.04
Current Price
$29.83
Current
$29.83
$29.83
Target
$62.44
$62.44
$34.96
$62.44 avg
$82.04
Scenario Analysis
Bear Case
$34.96
17.2%
Low target
Base Case
$62.44
+109.3%
Avg target
Bull Case
$82.04
+175.0%
High target
Risk/Reward
10.2x
Highly favorable
Price in Context
52-Week High
$40.37
-26.1% from high
52-Week Low
$4.30
+593.7% from low
Target vs 52W High
$62.44
+54.7% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 78% | $257.58 | +5.7% |
| AMGN | Hold | 44 | 50% | $190.87 | -46.4% |
| GILD | Strong Buy | 39 | 82% | $362.68 | +191.5% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -9.5% |
| REGN | Buy | 38 | 71% | $76.80 | -87.7% |
| ALNY | Strong Buy | 37 | 76% | $102.31 | -65.0% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -32.8% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -45.0% |